Format

Send to

Choose Destination
J Neuropathol Exp Neurol. 2019 Sep 28. pii: nlz086. doi: 10.1093/jnen/nlz086. [Epub ahead of print]

Desmoplastic Infantile Ganglioglioma: A MAPK Pathway-Driven and Microglia/Macrophage-Rich Neuroepithelial Tumor.

Author information

1
Departments of Laboratory Medicine and Pathology (MMB, PRB, EGBF, CDZ, RAJ, DM, JRB, RBJ, KCH, BRK, WRM, CMI), Health Sciences Research (AAN, JID), Pediatrics (AANR), Radiation Oncology (NNL), and Neurologic Surgery (DJD), Mayo Clinic, Rochester, Minnesota; and Departments of Pathology (CK) and Neuro-Oncology (VLH), Dell Children's Medical Center, Austin, Texas.

Abstract

MAPK pathway activation has been recurrently observed in desmoplastic infantile ganglioglioma/astrocytoma (DIG/DIA) with reported disproportionally low mutation allele frequencies relative to the apparent high tumor content, suggesting that MAPK pathway alterations may be subclonal. We sought to expand the number of molecularly profiled cases and investigate if tumor cell composition could account for the observed low mutation allele frequencies. Molecular (targeted neuro-oncology next-generation sequencing/RNA sequencing and OncoScan microarray) and immunohistochemical (CD68-PGM1/CD163/CD14/CD11c/lysozyme/CD3/CD20/CD34/PD-L1) studies were performed in 7 DIG. Activating MAPK pathway alterations were identified in 4 (57%) cases: 3 had a BRAF mutation (V600E/V600D/V600_W604delinsDQTDG, at 8%-27% variant allele frequency) and 1 showed a TPM3-NRTK1 fusion. Copy number changes were infrequent and nonrecurrent. All tumors had at least 30% of cells morphologically and immunophenotypically consistent with microglial/macrophage lineage. Two subtotally resected tumors regrew; 1 was re-excised and received adjuvant treatment (chemotherapy/targeted therapy), with clinical response to targeted therapy only. Even with residual tumor, all patients are alive (median follow-up, 83 months; 19-139). This study further supports DIG as another MAPK pathway-driven neuroepithelial tumor, thus expanding potential treatment options for tumors not amenable to surgical cure, and suggests that DIG is a microglia/macrophage-rich neuroepithelial tumor with frequent low driver mutation allele frequencies.

KEYWORDS:

BRAF; Desmoplastic infantile ganglioglioma (DIG); Glioma; Molecular; NTRK; Pediatric; TPM3

PMID:
31562743
DOI:
10.1093/jnen/nlz086

Supplemental Content

Full text links

Icon for Silverchair Information Systems
Loading ...
Support Center